Friday, May 1, 2026

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

U.S. Defense Strategy 2026: What Does the Omission of Extended Deterrence Mean for South Korea?

Trump's NDS omits "Extended Deterrence," raising concerns about U.S. nuclear support for South Korea amid shifting security strategies.

Tag: title track

No posts to display

Top News

- Our Sponsors Ad -

Follow us